3R在肿瘤药物筛选上的应用
中图分类号:

R965.1


Use of 3R in the Anti-tumor Drug Screening
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • | |
  • 文章评论
    摘要:

    目的探讨3R在肿瘤药物筛选上应用的可行性。方法(1)给KM小鼠接种S180、EAC、H22三株肿瘤,建立“一体三瘤”模型;(2)分别给KM小鼠接种S180或EAC或H22建立“一体单瘤”模型。给三瘤模型小鼠和单瘤模型小鼠口服待筛选的药物,观察药物对两种模型小鼠的抑瘤率以及其机体免疫功能的影响。结果(1)三瘤模型小鼠的各种瘤株与单瘤模型的相同瘤株相比,瘤体的生长缓慢。但没有影响对药物抑制肿瘤结果的判断。(2)三瘤模型和单瘤模型在小鼠的胸腺、脾以及DTH、廓清指数K、吞噬指数α等免疫参数上比较接近。结论“三瘤”模型小鼠可以用于肿瘤药物筛选中的抑瘤率和免疫功能实验。

    Abstract:

    Objective To investigate the possibility to use 3R(replacement,reduction,refinement) method in anti-tumor drug screening.Methods(1) The KM mice were inoculated with S-(180),H-(22) and EAC tumors to establish "three-tumors in one" model;(2) 1/3 KM mice were inoculated with S-(180),1/3 KM mice were inoculated with H-(22),the others were inoculated with EAC,to establish "one-tumor in one" model.The "three-tumors in one" model and the "one-tumor in one" model mice were infused with the anti-tumor drug per os,to observe the effect on the ratio of tumor inhibition and immune function.Results(1)The tumor growed slower in the "three-tumors in one" model mice than in "one-tumor in one" model,but there was no influence on the judgment of the drug's tumor-inhibition function.(2) The "three-tumors in one" model was very close to the "one-tumor in one "model in immunological parameter such as thymus,spleen,DTH,phagocytic and clearing indices.Conclusion The "three-tumors in one" model can be used to tumor inhibition and immune function experiments of the anti-tumor drug screening.

    参考文献
    相似文献
    引证文献
引用本文

卢笑丛 王有为 操继跃 龚复俊 斯缨 刘嵩 邬灏 吴娇.3R在肿瘤药物筛选上的应用[J].中国比较医学杂志,2005,(6):375~378.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2004-10-19
防诈骗提示!请勿点击不明链接或添加个人微信。编辑部所有邮箱后缀均为@cnilas.org
关闭